ACAD Rett Syndrome drug meets primary endpoints in
Post# of 1460
(Total Views: 384)
Posted On: 12/07/2021 1:35:03 PM
ACAD Rett Syndrome drug meets primary endpoints in Phase 3 clinical trial.
https://www.statnews.com/2021/12/06/acadia-dr...l-disease/
I hope AVXL's clinical trial is wrapping up soon, and that it is as good or better. I don't know the ACAD drug's mechanism of action. If the 2 drugs are synergistic that would be the best outcome for the patients, and both companies.
https://www.statnews.com/2021/12/06/acadia-dr...l-disease/
I hope AVXL's clinical trial is wrapping up soon, and that it is as good or better. I don't know the ACAD drug's mechanism of action. If the 2 drugs are synergistic that would be the best outcome for the patients, and both companies.
(2)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼